• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗酸剂和反流性食管炎作为胃底腺型胃肿瘤的一个危险因素:一项回顾性、匹配病例对照研究。

Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic-gland type: A retrospective, matched case-control study.

机构信息

Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.

Okinaka Memorial Institute for Medical Research, Tokyo, Japan.

出版信息

J Gastroenterol Hepatol. 2024 Aug;39(8):1580-1585. doi: 10.1111/jgh.16577. Epub 2024 Apr 20.

DOI:10.1111/jgh.16577
PMID:38641971
Abstract

BACKGROUND AND AIM

Since the first report of gastric adenocarcinoma of the fundic-gland type in 2010, the clinicopathological characteristics of gastric neoplasm of the fundic-gland type (GNFG) have become clearer; however, their risk factors remain unclear. This exploratory study aimed to identify the risk factors for GNFG.

METHODS

We conducted a single-center, retrospective, matched case-control study using medical information recorded at our health management center from January 2014 to July 2023. During this period, 39 240 people underwent upper gastrointestinal endoscopy. GNFG were extracted as cases and matched to controls, according to age and sex, in a 1:8 ratio, excluding those with a history of gastrointestinal surgery and those with a history or comorbidity of cancer. Univariate analysis was used to compare patient background and endoscopic findings. Multivariable analysis was performed, adjusting for factors with P values < 0.1 and antacid use.

RESULTS

A total of 20 GNFG cases and 160 matched healthy controls were included. In the univariate analysis, only reflux esophagitis was significantly more common in GNFG (40.0% vs 18.1%; P = 0.036). Factors antacids and duodenitis had P values < 0.1. Logistic regression analysis was performed, adjusting for antacids, reflux esophagitis, and duodenitis. Antacids and reflux esophagitis were the independent risk factors for GNFG (odds ratio = 3.68 [95% confidence interval: 1.04-11.91] and 3.25 [95% confidence interval: 1.11-9.35]).

CONCLUSIONS

Although the sample of patients with GNFG was small, antacids and reflux esophagitis were identified as a risk factor. The pathogenesis of antacids and reflux esophagitis may be involved in the development of GNFG.

摘要

背景与目的

自 2010 年首次报道胃底腺型胃腺癌以来,胃底腺型胃肿瘤(GNFG)的临床病理特征变得更加清晰;然而,其危险因素仍不清楚。本探索性研究旨在确定 GNFG 的危险因素。

方法

我们进行了一项单中心、回顾性、病例对照研究,使用了我们健康管理中心 2014 年 1 月至 2023 年 7 月记录的医疗信息。在此期间,有 39240 人接受了上消化道内镜检查。提取 GNFG 作为病例,并根据年龄和性别与对照组按 1:8 的比例进行匹配,排除有胃肠道手术史和有癌症病史或合并症的患者。采用单因素分析比较患者背景和内镜检查结果。进行多变量分析,调整 P 值<0.1 的因素和抗酸剂的使用。

结果

共纳入 20 例 GNFG 病例和 160 例匹配的健康对照者。在单因素分析中,仅反流性食管炎在 GNFG 中更为常见(40.0%比 18.1%;P=0.036)。抗酸剂和十二指肠炎的因素 P 值<0.1。进行了 logistic 回归分析,调整了抗酸剂、反流性食管炎和十二指肠炎。抗酸剂和反流性食管炎是 GNFG 的独立危险因素(比值比=3.68[95%置信区间:1.04-11.91]和 3.25[95%置信区间:1.11-9.35])。

结论

尽管 GNFG 患者的样本量较小,但抗酸剂和反流性食管炎被确定为危险因素。抗酸剂和反流性食管炎的发病机制可能与 GNFG 的发生有关。

相似文献

1
Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic-gland type: A retrospective, matched case-control study.抗酸剂和反流性食管炎作为胃底腺型胃肿瘤的一个危险因素:一项回顾性、匹配病例对照研究。
J Gastroenterol Hepatol. 2024 Aug;39(8):1580-1585. doi: 10.1111/jgh.16577. Epub 2024 Apr 20.
2
Comparison of Prognosis and Metachronous Gastric Tumor Rates After Endoscopic Submucosal Dissection Between Gastric Neoplasm of Fundic Gland Type Neoplasms and Conventional Gastric Adenocarcinoma.胃底腺型肿瘤与传统胃腺癌在内镜黏膜下剥离术后的预后及异时性胃肿瘤发生率比较
Cureus. 2024 Apr 17;16(4):e58467. doi: 10.7759/cureus.58467. eCollection 2024 Apr.
3
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.胃食管反流病、H2受体拮抗剂的使用与食管癌和胃癌风险
Cancer Causes Control. 2000 Mar;11(3):231-8. doi: 10.1023/a:1008913828105.
4
Risk factors for erosive reflux esophagitis: a case-control study.糜烂性反流性食管炎的危险因素:一项病例对照研究。
Am J Gastroenterol. 2001 Jan;96(1):41-6. doi: 10.1111/j.1572-0241.2001.03449.x.
5
Predictive factors of the long-term outcome in reflux esophagitis in a low-prevalence gastroesophageal reflux disease region.低患病率胃食管反流病地区反流性食管炎长期预后的预测因素
Scand J Gastroenterol. 2003 Nov;38(11):1131-5. doi: 10.1080/00365520310006171.
6
[Therapy of reflux esophagitis with antacids].[用抗酸剂治疗反流性食管炎]
Z Gastroenterol. 1983 Mar;21 Suppl:50-2.
7
High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients.伊朗患者上消化道内镜检查中反流性食管炎的高患病率。
Eur J Gastroenterol Hepatol. 2007 Jun;19(6):499-506. doi: 10.1097/MEG.0b013e32811ebfec.
8
The prevalence and risk factors of reflux esophagitis among adult Chinese population in Taiwan.台湾成年华人人群中反流性食管炎的患病率及危险因素
J Clin Gastroenterol. 2007 Oct;41(9):819-22. doi: 10.1097/01.mcg.0000225658.30803.79.
9
Reflux Esophagitis After Laparoscopic Pylorus-Preserving Gastrectomy for Gastric Cancer.腹腔镜保留幽门胃癌根治术后反流性食管炎
Ann Surg Oncol. 2023 Apr;30(4):2294-2303. doi: 10.1245/s10434-022-12902-5. Epub 2022 Dec 12.
10
Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
Scand J Gastroenterol Suppl. 1989;156:25-36.